Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 5180-5183, November 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Correction (v56,p935)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radford, D. M.
Right arrow Articles by Donis-Keller, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radford, D. M.
Right arrow Articles by Donis-Keller, H.

Allelic Loss and the Progression of Breast Cancer1

Diane M. Radford2, Nancy J. Phillips, Keri L. Fair, Jon H. Ritter, Matthew Holt and Helen Donis-Keller

Division of Human Molecular Genetics, Department of Surgery [D. M. R., K. L. F., M. H., H. D-K.] and Department of Pathology [J. H. R.], Washington University, St. Louis, Missouri 63110, and Department of Pathology, St. Louis University, St. Louis, Missouri 63110 [N. J. P.]

To study genetic changes and the evolution of breast cancer, we assayed for loss of heterozygosity (LOH) in 12 sets of synchronous carcinoma in situ (CIS) and invasive cancer, compared to normal control DNA. Microsatellite markers were used, which map to each nonacrocentric autosomal arm. Eight tumor sets demonstrated LOH of the same allele in both concurrent invasive cancer and ductal CIS, for a total of 18 chromosomal loci. Three of nine tumor sets showed LOH on 11p. In two of these sets, LOH was seen on 11p only in the invasive tumor, not the corresponding CIS. One of these tumors also exhibited allelic loss in the invasive tumor for 4 loci, all of which were retained in the noninvasive tumor. For two tumor sets, LOH was mirrored in matched ductal CIS, invasive tumor, and lymph node metastasis. The maintenance of LOH for certain loci throughout the stages of breast cancer suggests clonality of the cancer cells.

1 Supported by a Veterans Administration RAG grant, an American Cancer Society Career Development Award, USARDC Grant DAMD-94-J-4293 (to D.M.R.), and by NIH Grants HG00469 and HG01066 (to H. D. K.).

2 To whom requests for reprints should be addressed, at 9901 Wohl Hospital, 660 South Euclid Avenue, St. Louis, MO 63110.

Received 8/30/95. Accepted 9/28/95.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done
Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study
Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. S. Hwang, D. L. Miglioretti, R. Ballard-Barbash, D. L. Weaver, K. Kerlikowske, and for the National Cancer Institute Breast Cancer Su
Association between Breast Density and Subsequent Breast Cancer Following Treatment for Ductal Carcinoma In situ
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2587 - 2593.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. S. Hwang, J. L. McLennan, D. H. Moore, B. B. Crawford, L. J. Esserman, and J. L. Ziegler
Ductal Carcinoma In Situ in BRCA Mutation Carriers
J. Clin. Oncol., February 20, 2007; 25(6): 642 - 647.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. Arpino, R. Laucirica, and R. M. Elledge
Premalignant and In Situ Breast Disease: Biology and Clinical Implications
Ann Intern Med, September 20, 2005; 143(6): 446 - 457.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Jalota, K. Singh, L. Pavithra, R. Kaul-Ghanekar, S. Jameel, and S. Chattopadhyay
Tumor Suppressor SMAR1 Activates and Stabilizes p53 through Its Arginine-Serine-rich Motif
J. Biol. Chem., April 22, 2005; 280(16): 16019 - 16029.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. E. Ellsworth, D. L. Ellsworth, D. M. Neatrour, B. Deyarmin, S. M. Lubert, M. J. Sarachine, P. Brown, J. A. Hooke, and C. D. Shriver
Allelic Imbalance in Primary Breast Carcinomas and Metastatic Tumors of the Axillary Lymph Nodes
Mol. Cancer Res., February 1, 2005; 3(2): 71 - 77.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. S. Hwang, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, A. Thor, B.-M. Ljung, and F. M. Waldman
Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ
Clin. Cancer Res., August 1, 2004; 10(15): 5160 - 5167.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. J. Burstein, K. Polyak, J. S. Wong, S. C. Lester, and C. M. Kaelin
Ductal Carcinoma in Situ of the Breast
N. Engl. J. Med., April 1, 2004; 350(14): 1430 - 1441.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. M. Waldman, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, and B.-M. Ljung
Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences
J Natl Cancer Inst, February 16, 2000; 92(4): 313 - 320.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
X. Cui, H. Feiner, Z. Lin, and H. Li
Multiplex Genotype Analysis of Invasive Carcinoma and Accompanying Proliferative Lesions Microdissected from Breast Tissue
J. Mol. Diagn., February 1, 2000; 2(1): 29 - 36.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
X. q. Chen, H. Bonnefoi, S. Diebold-Berger, J. Lyautey, C. Lederrey, E. Faltin-Traub, M. Stroun, and P. Anker
Detecting Tumor-related Alterations in Plasma or Serum DNA of Patients Diagnosed with Breast Cancer
Clin. Cancer Res., September 1, 1999; 5(9): 2297 - 2303.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Hampl, J. A. Hampl, G. Reiss, G. Schackert, H.-D. Saeger, and H. K. Schackert
Loss of Heterozygosity Accumulation in Primary Breast Carcinomas and Additionally in Corresponding Distant Metastases Is Associated with Poor Outcome
Clin. Cancer Res., June 1, 1999; 5(6): 1417 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. I. Wistuba, C. Behrens, A. K. Virmani, S. Milchgrub, S. Syed, S. Lam, B. Mackay, J. D. Minna, and A. F. Gazdar
Allelic Losses at Chromosome 8p21-23 Are Early and Frequent Events in the Pathogenesis of Lung Cancer
Cancer Res., April 1, 1999; 59(8): 1973 - 1979.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. J Silverstein
Fortnightly review: Ductal carcinoma in situ of the breast
BMJ, September 12, 1998; 317(7160): 734 - 739.
[Full Text]


Home page
Am. J. Pathol.Home page
I. F. Newsham
The Long and Short of Chromosome 11 in Breast Cancer
Am. J. Pathol., July 1, 1998; 153(1): 5 - 9.
[Full Text] [PDF]


Home page
The OncologistHome page
M. J. Silverstein
Ductal Carcinoma In Situ of the Breast: Controversial Issues
Oncologist, April 1, 1998; 3(2): 94 - 103.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.